{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T04:16:17Z","timestamp":1787026577662,"version":"build-2736575974"},"reference-count":83,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Immunol."],"abstract":"<jats:p>Hyper-induction of pro-inflammatory cytokines, also known as a cytokine storm or cytokine release syndrome (CRS), is one of the key aspects of the currently ongoing SARS-CoV-2 pandemic. This process occurs when a large number of innate and adaptive immune cells activate and start producing pro-inflammatory cytokines, establishing an exacerbated feedback loop of inflammation. It is one of the factors contributing to the mortality observed with coronavirus 2019 (COVID-19) for a subgroup of patients. CRS is not unique to the SARS-CoV-2 infection; it was prevalent in most of the major human coronavirus and influenza A subtype outbreaks of the past two decades (H5N1, SARS-CoV, MERS-CoV, and H7N9). With a comprehensive literature search, we collected changing the cytokine levels from patients upon infection with the viral pathogens mentioned above. We analyzed published patient data to highlight the conserved and unique cytokine responses caused by these viruses. Our curation indicates that the cytokine response induced by SARS-CoV-2 is different compared to other CRS-causing respiratory viruses, as SARS-CoV-2 does not always induce specific cytokines like other coronaviruses or influenza do, such as IL-2, IL-10, IL-4, or IL-5. Comparing the collated cytokine responses caused by the analyzed viruses highlights a SARS-CoV-2-specific dysregulation of the type-I interferon (IFN) response and its downstream cytokine signatures. The map of responses gathered in this study could help specialists identify interventions that alleviate CRS in different diseases and evaluate whether they could be used in the COVID-19 cases.<\/jats:p>","DOI":"10.3389\/fimmu.2021.629193","type":"journal-article","created":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T23:16:20Z","timestamp":1614554180000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":104,"title":["SARS-CoV-2 Causes a Different Cytokine Response Compared to Other Cytokine Storm-Causing Respiratory Viruses in Severely Ill Patients"],"prefix":"10.3389","volume":"12","author":[{"given":"Marton","family":"Olbei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Hautefort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dezso","family":"Modos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agatha","family":"Treveil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Poletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lejla","family":"Gul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire D.","family":"Shannon-Lowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamas","family":"Korcsmaros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2021,3,1]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1016\/j.tips.2020.06.007","article-title":"Targeting JAK-STAT signaling to control cytokine release syndrome in COVID-19","volume":"41","author":"Luo","year":"2020","journal-title":"Trends Pharmacol Sci."},{"key":"B2","doi-asserted-by":"publisher","first-page":"327","DOI":"10.23812\/CONTI-E","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents."},{"key":"B3","doi-asserted-by":"publisher","first-page":"102537","DOI":"10.1016\/j.autrev.2020.102537","article-title":"The role of cytokines including interleukin-6 in COVID-19 induced pneumonia and macrophage activation syndrome-like disease","volume":"19","author":"McGonagle","year":"2020","journal-title":"Autoimmun Rev."},{"key":"B4","doi-asserted-by":"publisher","first-page":"108464","DOI":"10.1016\/j.clim.2020.108464","article-title":"Targeting T-cell senescence and cytokine storm with rapamycin to prevent severe progression in COVID-19","volume":"216","author":"Omarjee","year":"2020","journal-title":"Clin Immunol."},{"key":"B5","doi-asserted-by":"publisher","first-page":"179","DOI":"10.14744\/ejmo.2020.72142","article-title":"Cytokine-targeted therapy in severely ill COVID-19 patients: options and cautions","volume":"4","author":"Rahmati","year":"2020","journal-title":"EJMO."},{"key":"B6","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1016\/j.cell.2020.06.034","article-title":"The global phosphorylation landscape of SARS-CoV-2 infection","volume":"182","author":"Bouhaddou","year":"2020","journal-title":"Cell."},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1101\/2020.05.31.20112979","article-title":"An open resource for T cell phenotype changes in COVID-19 identifies IL-10-producing regulatory T cells as characteristic of severe cases","author":"Neumann","year":"2020","journal-title":"medRxiv [Preprint]"},{"key":"B8","doi-asserted-by":"publisher","first-page":"1003","DOI":"10.1093\/nsr\/nwaa037","article-title":"Elevated levels of plasma cytokines in COVID-19 reflect viral load and lung injury","volume":"7","author":"Liu","year":"2020","journal-title":"Natl Sci Rev."},{"key":"B9","doi-asserted-by":"publisher","first-page":"264","DOI":"10.1016\/j.coviro.2012.04.004","article-title":"SARS coronavirus pathogenesis: host innate immune responses and viral antagonism of interferon","volume":"2","author":"Totura","year":"2012","journal-title":"Curr Opin Virol."},{"key":"B10","doi-asserted-by":"publisher","first-page":"961","DOI":"10.3390\/v11100961","article-title":"Viral innate immune evasion and the pathogenesis of emerging RNA virus infections","volume":"11","author":"Nelemans","year":"2019","journal-title":"Viruses."},{"key":"B11","doi-asserted-by":"publisher","first-page":"185","DOI":"10.1002\/jmv.20255","article-title":"An interferon-gamma-related cytokine storm in SARS patients","volume":"75","author":"Huang","year":"2005","journal-title":"J Med Virol."},{"key":"B12","doi-asserted-by":"publisher","first-page":"5717108","DOI":"10.1155\/2016\/5717108","article-title":"Pains and gains from China's experiences with emerging epidemics: from SARS to H7N9","volume":"2016","author":"Wei","year":"2016","journal-title":"Biomed Res Int."},{"key":"B13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1056\/NEJMp2000929","article-title":"A novel coronavirus emerging in China - key questions for impact assessment","volume":"382","author":"Munster","year":"2020","journal-title":"N Engl J Med."},{"key":"B14","doi-asserted-by":"publisher","first-page":"2202","DOI":"10.1172\/JCI137647","article-title":"SARS-CoV-2: a storm is raging","volume":"130","author":"Pedersen","year":"2020","journal-title":"J Clin Invest."},{"key":"B15","doi-asserted-by":"publisher","first-page":"607","DOI":"10.1016\/j.jinf.2020.03.037","article-title":"The pathogenesis and treatment of the \u2018cytokine storm\u2019 in COVID-19","volume":"80","author":"Ye","year":"2020","journal-title":"J Infect."},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1038\/s41422-020-00455-9","article-title":"Discriminating mild from critical COVID-19 by innate and adaptive immune single-cell profiling of bronchoalveolar lavages","author":"Wauters","year":"2021","journal-title":"Cell Res."},{"key":"B17","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1128\/MMBR.05015-11","article-title":"Into the eye of the cytokine storm","volume":"76","author":"Tisoncik","year":"2012","journal-title":"Microbiol Mol Biol Rev."},{"key":"B18","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s40425-018-0343-9","article-title":"Cytokine release syndrome","volume":"6","author":"Shimabukuro-Vornhagen","year":"2018","journal-title":"J Immunother Cancer."},{"key":"B19","doi-asserted-by":"publisher","first-page":"S1","DOI":"10.1186\/ar2881","article-title":"Overview of the biology of type I interferons","volume":"12","author":"Kalliolias","year":"2010","journal-title":"Arthritis Res Ther."},{"key":"B20","doi-asserted-by":"publisher","first-page":"975","DOI":"10.1038\/nrd2422","article-title":"Interferons at age 50: past, current and future impact on biomedicine","volume":"6","author":"Borden","year":"2007","journal-title":"Nat Rev Drug Discov."},{"key":"B21","doi-asserted-by":"publisher","first-page":"145","DOI":"10.1186\/1743-422X-9-145","article-title":"Avian influenza virus H5N1 induces rapid interferon-beta production but shows more potent inhibition to retinoic acid-inducible gene I expression than H1N1 in vitro","volume":"9","author":"Mi","year":"2012","journal-title":"Virol J."},{"key":"B22","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1189\/jlb.71.4.565","article-title":"Interferon-\u03b1 as an immunotherapeutic protein","volume":"71","author":"Brassard","year":"2002","journal-title":"J Leukoc Biol."},{"key":"B23","doi-asserted-by":"publisher","first-page":"2061","DOI":"10.3389\/fimmu.2018.02061","article-title":"The dual nature of type I and type II interferons","volume":"9","author":"Lee","year":"2018","journal-title":"Front Immunol."},{"key":"B24","doi-asserted-by":"publisher","first-page":"e33","DOI":"10.4110\/in.2018.18.e33","article-title":"Direct antiviral mechanisms of interferon-gamma","volume":"18","author":"Kang","year":"2018","journal-title":"Immune Netw."},{"key":"B25","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1172\/JCI118843","article-title":"IL-12 in conjunction with dendritic cells enhances antiviral CD8+ CTL responses in vitro","volume":"98","author":"Bhardwaj","year":"1996","journal-title":"J Clin Invest."},{"key":"B26","doi-asserted-by":"publisher","first-page":"e0123087","DOI":"10.1371\/journal.pone.0123087","article-title":"Type I interferon response is delayed in human astrovirus infections","volume":"10","author":"Guix","year":"2015","journal-title":"PLoS ONE."},{"key":"B27","doi-asserted-by":"publisher","first-page":"609","DOI":"10.3389\/fimmu.2016.00609","article-title":"Type-I interferon responses: from friend to foe in the battle against chronic viral infection","volume":"7","author":"Murira","year":"2016","journal-title":"Front Immunol."},{"key":"B28","doi-asserted-by":"publisher","first-page":"S103","DOI":"10.3978\/j.issn.2072-1439.2013.06.02","article-title":"From SARS coronavirus to novel animal and human coronaviruses","volume":"5","author":"To","year":"2013","journal-title":"J Thorac Dis."},{"key":"B29","doi-asserted-by":"publisher","first-page":"3625","DOI":"10.1172\/JCI126363","article-title":"IFN-I response timing relative to virus replication determines MERS coronavirus infection outcomes","volume":"29","author":"Channappanavar","year":"2019","journal-title":"J Clin Investig."},{"key":"B30","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.chom.2016.01.007","article-title":"Dysregulated type I interferon and inflammatory monocyte-macrophage responses cause lethal pneumonia in SARS-CoV-infected mice","volume":"19","author":"Channappanavar","year":"2016","journal-title":"Cell Host Microbe."},{"key":"B31","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1002\/jmv.20556","article-title":"Cytokine regulation in SARS coronavirus infection compared to other respiratory virus infections","volume":"78","author":"Okabayashi","year":"2006","journal-title":"J Med Virol."},{"key":"B32","doi-asserted-by":"publisher","first-page":"s12","DOI":"10.7861\/clinmedicine.14-6-s12","article-title":"Novel respiratory viruses: what should the clinician be alert for?","volume":"14","author":"Payne","year":"2014","journal-title":"Clin Med."},{"key":"B33","doi-asserted-by":"publisher","first-page":"209","DOI":"10.1038\/mi.2017.41","article-title":"IFN-\u03b3 increases susceptibility to influenza A infection through suppression of group II innate lymphoid cells","volume":"11","author":"Califano","year":"2018","journal-title":"Mucosal Immunol."},{"key":"B34","doi-asserted-by":"publisher","first-page":"7639","DOI":"10.18632\/aging.103101","article-title":"Immune environment modulation in pneumonia patients caused by coronavirus: SARS-CoV, MERS-CoV and SARS-CoV-2","volume":"12","author":"Yao","year":"2020","journal-title":"Aging."},{"key":"B35","doi-asserted-by":"publisher","first-page":"4655","DOI":"10.1128\/JVI.03095-14","article-title":"A(H7N9) virus results in early induction of proinflammatory cytokine responses in both human lung epithelial and endothelial cells and shows increased human adaptation compared with avian H5N1 virus","volume":"89","author":"Zeng","year":"2015","journal-title":"J Virol."},{"key":"B36","doi-asserted-by":"publisher","first-page":"1203","DOI":"10.1038\/nm1477","article-title":"Fatal outcome of human influenza A (H5N1) is associated with high viral load and hypercytokinemia","volume":"12","author":"de Jong","year":"2006","journal-title":"Nat Med."},{"key":"B37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1038\/s41577-020-0346-x","article-title":"Dysregulation of type I interferon responses in COVID-19","volume":"20","author":"Acharya","year":"2020","journal-title":"Nat Rev Immunol."},{"key":"B38","doi-asserted-by":"publisher","first-page":"e00728","DOI":"10.1128\/JVI.00728-18","article-title":"The coronavirus transmissible gastroenteritis virus evades the type i interferon response through IRE1\u03b1-mediated manipulation of the MicroRNA miR-30a-5p\/SOCS1\/3 Axis","volume":"92","author":"Ma","year":"2018","journal-title":"J Virol."},{"key":"B39","doi-asserted-by":"publisher","first-page":"1475","DOI":"10.1016\/j.cell.2020.05.006","article-title":"Host-viral infection maps reveal signatures of severe COVID-19 patients","volume":"181","author":"Bost","year":"2020","journal-title":"Cell."},{"key":"B40","doi-asserted-by":"crossref","first-page":"p. 500","DOI":"10.1016\/B978-012373944-5.00314-X","article-title":"Respiratory viruses","volume-title":"Encyclopedia of Microbiology","author":"Boncristiani","year":"2009"},{"key":"B41","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1111\/irv.12575","article-title":"Clinical characteristics and severity of influenza infections by virus type, subtype, and lineage: a systematic literature review","volume":"12","author":"Caini","year":"2018","journal-title":"Influenza Other Respir Viruses."},{"key":"B42","doi-asserted-by":"publisher","first-page":"236","DOI":"10.1016\/j.micinf.2020.05.005","article-title":"Comparative review of respiratory diseases caused by coronaviruses and influenza A viruses during epidemic season","volume":"22","author":"Jiang","year":"2020","journal-title":"Microbes Infect."},{"key":"B43","doi-asserted-by":"publisher","first-page":"729","DOI":"10.1016\/j.cmi.2020.03.026","article-title":"COVID-19, SARS and MERS: are they closely related?","volume":"26","author":"Petrosillo","year":"2020","journal-title":"Clin Microbiol Infect."},{"key":"B44","doi-asserted-by":"publisher","first-page":"e14","DOI":"10.1016\/S2666-5247(20)30004-5","article-title":"Comparative tropism, replication kinetics, and cell damage profiling of SARS-CoV-2 and SARS-CoV with implications for clinical manifestations, transmissibility, and laboratory studies of COVID-19: an observational study","volume":"1","author":"Chu","year":"2020","journal-title":"Lancet Microbe."},{"key":"B45","doi-asserted-by":"publisher","first-page":"2781","DOI":"10.26355\/eurrev_202003_20551","article-title":"Differences and similarities between Severe Acute Respiratory Syndrome (SARS)-CoronaVirus (CoV) and SARS-CoV-2. Would a rose by another name smell as sweet?","volume":"24","author":"Ceccarelli","year":"2020","journal-title":"Eur Rev Med Pharmacol Sci."},{"key":"B46","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1007\/978-1-4615-0171-8_2","article-title":"Cytokines and chemokines-their receptors and their genes: an overview","volume":"520","author":"Cameron","year":"2003","journal-title":"Adv. Exp. Med. Biol."},{"key":"B47","doi-asserted-by":"publisher","first-page":"W587","DOI":"10.1093\/nar\/gkz389","article-title":"PubTator central: automated concept annotation for biomedical full text articles","volume":"47","author":"Wei","year":"2019","journal-title":"Nucleic Acids Res."},{"key":"B48","volume-title":"Mwaskom\/Seaborn: V0.8.1 (September 2017)","author":"Waskom","year":"2017"},{"key":"B49","doi-asserted-by":"publisher","first-page":"37","DOI":"10.1111\/j.1469-8137.1912.tb05611.x","article-title":"The distribution of the flora in the alpine zone","volume":"11","author":"Jaccard","year":"1912","journal-title":"New Phytol."},{"key":"B50","doi-asserted-by":"publisher","first-page":"805","DOI":"10.1177\/001316446002000418","article-title":"Comprehensive hierarchical analysis","volume":"20","author":"Mcquitty","year":"1960","journal-title":"Educ Psychol Meas."},{"key":"B51","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1080\/03610910903168603","article-title":"A comparison of hierarchical methods for clustering functional data","volume":"38","author":"Ferreira","year":"2009","journal-title":"Commun Stat Simul Comput."},{"key":"B52","doi-asserted-by":"publisher","first-page":"760","DOI":"10.1002\/jmv.23492","article-title":"Clinical symptoms, immune factors, and molecular characteristics of an adult male in Shenzhen, China infected with influenza virus H5N1","volume":"85","author":"Wu","year":"2013","journal-title":"J Med Virol."},{"key":"B53","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1007\/s00281-017-0636-y","article-title":"New fronts emerge in the influenza cytokine storm","volume":"39","author":"Guo","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B54","doi-asserted-by":"publisher","first-page":"33","DOI":"10.1038\/s41392-020-0148-4","article-title":"Lymphopenia predicts disease severity of COVID-19: a descriptive and predictive study","volume":"5","author":"Tan","year":"2020","journal-title":"Signal Transduct Target Ther."},{"key":"B55","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1016\/j.cytogfr.2017.08.002","article-title":"Immunobiology of the IL-15\/IL-15R\u03b1 complex as an antitumor and antiviral agent","volume":"38","author":"Guo","year":"2017","journal-title":"Cytok Growth Factor Rev."},{"key":"B56","doi-asserted-by":"publisher","first-page":"481","DOI":"10.1128\/CMR.00090-16","article-title":"The human immune response to respiratory syncytial virus infection","volume":"30","author":"Russell","year":"2017","journal-title":"Clin Microbiol Rev."},{"key":"B57","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1038\/nature12379","article-title":"Biological features of novel avian influenza A (H7N9) virus","volume":"499","author":"Zhou","year":"2013","journal-title":"Nature."},{"key":"B58","doi-asserted-by":"publisher","DOI":"10.2139\/ssrn.3564998","article-title":"Viral invasion and type I interferon response characterize the immunophenotypes during COVID-19 infection","author":"Wei","year":"2020","journal-title":"SSRN Electron J."},{"key":"B59","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1128\/CMR.00102-14","article-title":"Middle East respiratory syndrome coronavirus: another zoonotic betacoronavirus causing SARS-like disease","volume":"28","author":"Chan","year":"2015","journal-title":"Clin Microbiol Rev."},{"key":"B60","doi-asserted-by":"publisher","first-page":"18","DOI":"10.3389\/fimmu.2013.00018","article-title":"Pro-inflammatory signaling by IL-10 and IL-22: bad habit stirred up by interferons?","volume":"4","author":"M\u00fchl","year":"2013","journal-title":"Front Immunol."},{"key":"B61","doi-asserted-by":"publisher","first-page":"2783","DOI":"10.4049\/jimmunol.165.5.2783","article-title":"Proinflammatory effects of IL-10 during human endotoxemia","volume":"165","author":"Lauw","year":"2000","journal-title":"J Immunol."},{"key":"B62","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1007\/s00281-017-0629-x","article-title":"Pathogenic human coronavirus infections: causes and consequences of cytokine storm and immunopathology","volume":"39","author":"Channappanavar","year":"2017","journal-title":"Semin Immunopathol."},{"key":"B63","doi-asserted-by":"publisher","first-page":"1967","DOI":"10.1056\/NEJMoa030747","article-title":"Identification of a novel coronavirus in patients with severe acute respiratory syndrome","volume":"348","author":"Drosten","year":"2003","journal-title":"N Engl J Med."},{"key":"B64","doi-asserted-by":"publisher","first-page":"1319","DOI":"10.1016\/S0140-6736(03)13077-2","article-title":"Coronavirus as a possible cause of severe acute respiratory syndrome","volume":"361","author":"Peiris","year":"2003","journal-title":"Lancet."},{"key":"B65","doi-asserted-by":"publisher","first-page":"e00473","DOI":"10.1128\/mBio.00473-12","article-title":"Genomic characterization of a newly discovered coronavirus associated with acute respiratory distress syndrome in humans","volume":"3","author":"van Boheemen","year":"2012","journal-title":"MBio."},{"key":"B66","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1016\/S0140-6736(03)13967-0","article-title":"Newly discovered coronavirus as the primary cause of severe acute respiratory syndrome","volume":"362","author":"Kuiken","year":"2003","journal-title":"Lancet."},{"key":"B67","doi-asserted-by":"publisher","first-page":"593857","DOI":"10.3389\/fmicb.2020.593857","article-title":"Comparative transcriptome analysis reveals the intensive early stage responses of host cells to SARS-CoV-2 infection","volume":"11","author":"Sun","year":"2020","journal-title":"Front Microbiol."},{"key":"B68","doi-asserted-by":"publisher","first-page":"715","DOI":"10.1111\/j.1440-1843.2006.00942.x","article-title":"Temporal changes in cytokine\/chemokine profiles and pulmonary involvement in severe acute respiratory syndrome","volume":"11","author":"Chien","year":"2006","journal-title":"Respirology."},{"key":"B69","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.cyto.2018.01.025","article-title":"MERS-CoV infection in humans is associated with a pro-inflammatory Th1 and Th17 cytokine profile","volume":"104","author":"Mahallawi","year":"2018","journal-title":"Cytokine."},{"key":"B70","doi-asserted-by":"publisher","first-page":"1717","DOI":"10.3346\/jkms.2016.31.11.1717","article-title":"Clinical progression and cytokine profiles of middle east respiratory syndrome coronavirus infection","volume":"31","author":"Kim","year":"2016","journal-title":"J Korean Med Sci."},{"key":"B71","doi-asserted-by":"publisher","first-page":"971","DOI":"10.2217\/fvl.15.62","article-title":"H5N1 influenza virulence, pathogenicity and transmissibility: what do we know?","volume":"10","author":"Neumann","year":"2015","journal-title":"Future Virol."},{"key":"B72","doi-asserted-by":"publisher","first-page":"3363","DOI":"10.3390\/v4123363","article-title":"Innate immunity to H5N1 influenza viruses in humans","volume":"4","author":"Ramos","year":"2012","journal-title":"Viruses."},{"key":"B73","doi-asserted-by":"publisher","first-page":"382","DOI":"10.4049\/jimmunol.1801070","article-title":"Immune responses to avian influenza viruses","volume":"202","author":"Koutsakos","year":"2019","journal-title":"J Immunol."},{"key":"B74","doi-asserted-by":"publisher","DOI":"10.1016\/j.jmii.2020.04.013","article-title":"A cluster of health care workers with COVID-19 pneumonia caused by SARS-CoV-2","author":"Wei","year":"2020","journal-title":"J Microbiol Immunol Infect."},{"key":"B75","doi-asserted-by":"publisher","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet."},{"key":"B76","doi-asserted-by":"publisher","first-page":"998","DOI":"10.1093\/nsr\/nwaa041","article-title":"Pathogenic T cells and inflammatory monocytes incite inflammatory storm in severe COVID-19 patients","volume":"7","author":"Zhou","year":"2020","journal-title":"Natl Sci Rev."},{"key":"B77","doi-asserted-by":"publisher","first-page":"827","DOI":"10.3389\/fimmu.2020.00827","article-title":"Reduction and functional exhaustion of T cells in patients with coronavirus disease 2019 (COVID-19)","volume":"11","author":"Diao","year":"2020","journal-title":"Front Immunol"},{"key":"B78","doi-asserted-by":"publisher","DOI":"10.1111\/joim.13162","article-title":"Tocilizumab shortens time on mechanical ventilation and length of hospital stay in patients with severe COVID-19: a retrospective cohort study","author":"Eimer","year":"2020","journal-title":"J Intern Med."},{"key":"B79","doi-asserted-by":"publisher","first-page":"595","DOI":"10.1016\/j.arcmed.2020.05.009","article-title":"Tocilizumab: a therapeutic option for the treatment of cytokine storm syndrome in COVID-19","volume":"51","author":"Saha","year":"2020","journal-title":"Arch Med Res."},{"key":"B80","doi-asserted-by":"publisher","first-page":"2260","DOI":"10.1002\/jmv.26078","article-title":"COVID-19: consider IL-6 receptor antagonist for the therapy of cytokine storm syndrome in SARS-CoV-2 infected patients","volume":"92","author":"Chakraborty","year":"2020","journal-title":"J Med Virol."},{"key":"B81","doi-asserted-by":"publisher","first-page":"e1008685","DOI":"10.1371\/journal.pcbi.1008685","article-title":"ViralLink: an integrated workflow to investigate the effect of SARS-CoV-2 on intracellular signalling and regulatory pathways","volume":"17","author":"Treveil","year":"2021","journal-title":"PLoS Comput Biol."},{"key":"B82","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1186\/s12859-020-03935-2","article-title":"H2V: a database of human genes and proteins that respond to SARS-CoV-2, SARS-CoV, and MERS-CoV infection","volume":"22","author":"Zhou","year":"2021","journal-title":"BMC Bioinformatics."},{"key":"B83","doi-asserted-by":"publisher","first-page":"D1534","DOI":"10.1093\/nar\/gkaa952","article-title":"LitCovid: an open database of COVID-19 literature","volume":"49","author":"Chen","year":"2021","journal-title":"Nucleic Acids Res."}],"container-title":["Frontiers in Immunology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.629193\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,2,28]],"date-time":"2021-02-28T23:16:25Z","timestamp":1614554185000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fimmu.2021.629193\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,3,1]]},"references-count":83,"alternative-id":["10.3389\/fimmu.2021.629193"],"URL":"https:\/\/doi.org\/10.3389\/fimmu.2021.629193","relation":{"has-preprint":[{"id-type":"doi","id":"10.1101\/2020.11.14.20231878","asserted-by":"object"}]},"ISSN":["1664-3224"],"issn-type":[{"value":"1664-3224","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,3,1]]},"article-number":"629193"}}